This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,381.98 firm fixed-price contract is for the delivery of 4,566,499,872 units of Vyvanse 10 mg capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD).
The award is not designated as a set-aside contract. It falls under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract term runs through November 2026.
Generated 2/19/25, 9:26 AM